Bruker Corporation and Atinary Technologies expand strategic collaboration near Basel, Switzerland; minority investment and SDLabs integration.

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories • Biopôle

Community Overview Life sciences companies Research institutes Stories

Spaces Overview Office spaces Laboratory spaces Services & Amenities

Programmes Overview Biopôle Investment Programme Vanguard Accelerator Corporate Partnerships

Careers Overview Postgrad Consulting Programme Master’s internships Biopôle’s podcast Jobs

About Biopôle SA Campus Region History Impact Annual Review

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Corporation announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary. Financial details were not disclosed.

Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY scientific software into its agentic AI workflows. Atinary’s code-free SDLabs® platform applies AI agents and machine learning to design optimal experiments and deliver better and faster results with automated closed-loop Design-Make-Test-Analyze-Learn workflows. Running these integrated workflows generates high-quality, reproducible, and AI-ready datasets that are essential to train better models, increase success rates, and accelerate discovery.

Atinary and Chemspeed have established a joint demonstration laboratory at Chemspeed’s headquarters near Basel, Switzerland. Atinary’s Self-Driving Lab in Boston opened in early 2026 as a Scientific Data Factory to bring better molecules and products to market faster. The Atinary Lab includes Chemspeed robotics and Bruker benchtop NMR, as well as automation and measurement tools by other vendors, focusing on small-molecule synthesis and catalysis in pharmaceutical R&D and process development.

Company related to the news

News > Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

News > Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Route de la Corniche 8

Life sciences entrepreneurs at Biopôle never stop innovating. Enter your e-mail and get monthly updates delivered to your inbox